Metabolism - Clinical and Experimental
Volume 44, Issue 11 , Pages 1413-1416, November 1995

The effects of weight reduction to ideal body weight on body fat distribution

  • Rosa G. Hendler

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Rosa G. Hendler, MD, Yale University School of Medicine, Department of Internal Medicine, Fitkin 103, 333 Cedar St, New Haven, CT 06520-8020.
    • Department of Medicine, Endocrine Section, Yale University School of Medicine, New Haven, CT, USA
    • Department of Medicine, Endocrine Metabolism Unit, University of Rochester School of Medicine, Rochester, NY, USA
    • Monroe Community Hospital, Rochester, NY, USA
    • Miles Pharmaceutical Division, West Haven, CT, USA
  • ,
  • Stephen L. Welle

      Affiliations

    • Department of Medicine, Endocrine Section, Yale University School of Medicine, New Haven, CT, USA
    • Department of Medicine, Endocrine Metabolism Unit, University of Rochester School of Medicine, Rochester, NY, USA
    • Monroe Community Hospital, Rochester, NY, USA
    • Miles Pharmaceutical Division, West Haven, CT, USA
  • ,
  • Marcia C. Statt

      Affiliations

    • Department of Medicine, Endocrine Section, Yale University School of Medicine, New Haven, CT, USA
    • Department of Medicine, Endocrine Metabolism Unit, University of Rochester School of Medicine, Rochester, NY, USA
    • Monroe Community Hospital, Rochester, NY, USA
    • Miles Pharmaceutical Division, West Haven, CT, USA
  • ,
  • Roger Barnard

      Affiliations

    • Department of Medicine, Endocrine Section, Yale University School of Medicine, New Haven, CT, USA
    • Department of Medicine, Endocrine Metabolism Unit, University of Rochester School of Medicine, Rochester, NY, USA
    • Monroe Community Hospital, Rochester, NY, USA
    • Miles Pharmaceutical Division, West Haven, CT, USA
  • ,
  • John M. Amatruda

      Affiliations

    • Department of Medicine, Endocrine Section, Yale University School of Medicine, New Haven, CT, USA
    • Department of Medicine, Endocrine Metabolism Unit, University of Rochester School of Medicine, Rochester, NY, USA
    • Monroe Community Hospital, Rochester, NY, USA
    • Miles Pharmaceutical Division, West Haven, CT, USA

Received 29 July 1994; accepted 21 March 1995.

Abstract 

Obesity is a well-known health risk factor. Several studies have demonstrated that upper-body fat distribution plays a major role in the association between increased adiposity and metabolic disorders. The present study was undertaken to evaluate changes in intraabdominal and subcutaneous fat areas in obese subjects undergoing a weight reduction to their ideal body weight (IBW), as defined by a body mass index (BMI) no greater than 21 or body fat less than 30%, and compare the fat distribution at IBW with that of never-obese control subjects. We studied 33 obese women (151% ± 1% of IBW; BMI, 31.6 ± 2.5 [mean ± SE]) before and after weight loss and a control group of 16 never-obese women (101.0% ± 1.0% of IBW; BMI, 21.2 ± 1.1). Eighteen obese women successfully achieved and stabilized at IBW for at least 2 months. Nonsuccessful obese subjects were significantly younger than reduced-weight subjects, but other physical characteristics were similar. In obese, reduced-obese, and never-obese groups, weight was 85 ± 2.0, 62 ± 1, and 58 ± 1 kg; percent body fat was 41% ± 1%, 24% ± 2%, and 23% ± 1%; intraabdominal fat area was 82 ± 5, 28 ± 3, and 25 ± 4 cm2; waist subcutaneous fat area was 275 ± 15, 120 ± 9, and 81 ± 7 cm2; hip subcutaneous fat area was 416 ± 17,204 ± 10, and 195 ± 7 cm2; and waist to hip ratio (WHR) was 0.84 ± 0.02, 0.77 ± 0.01, and 0.73 ± 0.01, respectively. Our findings indicate that with weight reduction to IBW, intraabdominal and hip subcutaneous fat areas are the same as in individuals who are at IBW, BMI 21.1, and have never been obese. WHR and waist subcutaneous fat area remain significantly increased as compared with those in never-obese controls (P < .05).

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by National Institutes of Health Grants No. DK40816, RR00044, and RR000125.

PII: 0026-0495(95)90139-6

Metabolism - Clinical and Experimental
Volume 44, Issue 11 , Pages 1413-1416, November 1995